Agilent Technologies Inc. (Santa Clara, California) has agreed to support research by Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College (New York, New York), into amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Agilent Technologies Inc. (Santa Clara, California) has agreed to support research by Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College (New York, New York), into amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Agilent will provide the latest mass spectrometry technology to support this research, which aims to achieve an understanding of how the most common form of this disease develops in the body.
Gross is an internationally recognized expert in the use of mass spectrometry-based metabolomics. His expertise is in pharmacology and cell biology, particularly in relation to the role of nitric oxide as a signaling molecule. Through the partnership, Agilent will provide two mass spectrometers for Gross’s laboratory.
Sporadic amyotrophic lateral sclerosis (sALS) accounts for about 90 percent of all ALS cases and has no obvious genetic driver. Gross and his collaborators-Giovanni Manfredi, a professor of neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell, and Lorenz Studer, director of Sloan Kettering Institute’s Center for Stem Cell Biology-are investigating the molecular underpinnings of this form of ALS. The Agilent tools will assist the investigators in applying a multi-disciplinary-based approach to understanding the roots of this disease. Specifically, accurate-mass spectrometry will enable the researchers to test the hypothesis that fibroblasts express systemic metabolic markers that inform ALS.
Maximizing Cannabinoid Separation for Potency Testing with LC
April 7th 2025Researchers from the Department of Chemistry at Western Illinois University (Macomb, Illinois) conducted a study to optimize the separation of 18 cannabinoids for potency testing of hemp-based products, using liquid chromatography with a diode array detector (LC–DAD). As part of our monthlong series of articles pertaining to National Cannabis Awareness Month, LCGC International spoke to Liguo Song, the corresponding author of the paper stemming from this research, to discuss the study and its findings.
How Many Repetitions Do I Need? Caught Between Sound Statistics and Chromatographic Practice
April 7th 2025In chromatographic analysis, the number of repeated measurements is often limited due to time, cost, and sample availability constraints. It is therefore not uncommon for chromatographers to do a single measurement.